Analyst Ratings For Seattle Genetics (NASDAQ:SGEN)
Today, Seattle Genetics (NASDAQ:SGEN) stock received an upgrade by JPMorgan Chase & Co. from Neutral to Overweight with a price target of $60.00.
Some recent analyst ratings include
- 2/14/2018-JPMorgan Chase & Co. Upgrade from a “Neutral ” rating to a ” Overweight” rating.
- 2/7/2018-Needham & Company LLC Reiterated Rating of Buy .
- 2/7/2018-SunTrust Banks Reiterated Rating of Hold.
- 2/7/2018-HC Wainwright Reiterated Rating of Buy.
- 1/2/2018-Oppenheimer Reiterated Rating of Hold.
Recent Insider Trading Activity For Seattle Genetics (NASDAQ:SGEN)
Seattle Genetics (NASDAQ:SGEN) has insider ownership of 34.70% and institutional ownership of 91.60%.
- On 2/9/2018 Clay B. Siegall, Insider, sold 18,832 with an average share price of $49.75 per share and the total transaction amounting to $936,892.00.
- On 2/1/2018 Bros. Advisors Lp Baker, Director, bought 3,846,153 with an average share price of $52.00 per share and the total transaction amounting to $199,999,956.00.
- On 1/11/2018 Clay B. Siegall, Insider, sold 18,832 with an average share price of $51.71 per share and the total transaction amounting to $973,802.72.
- On 12/11/2017 Clay B. Siegall, Insider, sold 18,832 with an average share price of $55.40 per share and the total transaction amounting to $1,043,292.80.
- On 12/4/2017 Eric Dobmeier, COO, sold 3,729 with an average share price of $58.75 per share and the total transaction amounting to $219,078.75.
- On 11/30/2017 Vaughn B. Himes, Insider, sold 10,000 with an average share price of $59.97 per share and the total transaction amounting to $599,700.00.
- On 11/17/2017 Eric Dobmeier, COO, sold 35,000 with an average share price of $58.25 per share and the total transaction amounting to $2,038,750.00.
Recent Trading Activity for Seattle Genetics (NASDAQ:SGEN)
Shares of Seattle Genetics closed the previous trading session at 53.85 up +1.70 3.26% with 53.619998931884766 shares trading hands.